Coking Coal Import Can't Be Fully Substituted: CIL MD
Oct 21, 2024 17:45
CIL MD says coking coal import cannot be fully substituted, but can be reduced by increasing domestic production. Import reduction aims to achieve 1.5 billion tonne coal production in 4-5 years.
Photograph: Amit Dave/Reuters
New Delhi, Oct 21 (PTI) CIL Chairman and Managing Director P M Prasad on Monday said coking coal import cannot be substituted fully, but some part of it can be reduced.
Coking coal, also known as metallurgical coal, is used to produce coke, a key component in steel-making process.
As per the data compiled by mjunction services ltd, India's coal import in 2023-24 was 268.24 MT, which includes 57.22 MT coking coal and 175.96 MT non-coking coal.
Speaking during stakeholders' consultation on mining operators-cum-developers (MDO) and Star Rating of Coal Mines Award Ceremony, the CMD said coking coal import cannot be substituted fully, but some part of it can be reduced.
The coking coal import can be brought down if its production through domestic sources is increased, he noted.
He further said achieving coal production of 1.5 billion tonne in the next four to five years is not a small thing and in order to achieve this output, mining projects have to be awarded to MDOs.
Import of thermal coal can be reduced to a larger extent, once coal production of 1.5 billion tonne is achieved.
"To achieve 500 million tonne in next five years is a huge task. When we work together it will be possible," he explained.
The all-India production of coal during 2023-24 was 997.83 MT.
Coal India accounts for over 80 per cent of domestic coal output.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
MORE NEWS
Equity MF Inflow Drops 14% to Rs 25,082 cr in...
Equity mutual fund inflows declined 14% to Rs 25,082 crore in March, marking the third...
Morepen to Hire 1,000 Medical Reps to Boost...
Morepen Laboratories plans to hire over 1,000 medical representatives in the next three...
Madhur Bajaj, Bajaj Auto Non-Executive...
Madhur Bajaj, non-executive director at Bajaj Auto Ltd, passed away at a Mumbai...
Cipla Gets USFDA Approval for Generic Cancer Drug
Cipla receives USFDA approval for its generic cancer treatment drug, paclitaxel...
HMSI Recalls CB300R Motorcycles for Headlight...
Honda Motorcycle & Scooter India (HMSI) is recalling certain CB300R motorcycles...
Indian Real Estate Investment Surges 74% in Q1...
India's real estate sector witnessed a 74% rise in equity investment during Jan-Mar...
India Stock Markets Surge as US Suspends Tariffs
Indian stock markets surged on Friday after the US announced the suspension of...
Rupee Rises 51 Paise to 86.17 Against US Dollar
The Indian rupee strengthened against the US dollar in early trade on Friday, driven by...
Rupee Rises 51 Paise to 86.17 vs US Dollar
The Indian rupee strengthened against the US dollar in early trade on Friday, driven by...
India's Export Opportunity: US Tariffs on China
High tariffs on Chinese goods in the US could boost Indian exports in sectors like...
Read More »